Determination of bisphosphonate properties in terms of bioavailability, bone affinity, and cytotoxicity.

The findings suggest that BP3 BP8, and BP11 are promising candidates for further research. These results highlight the importance of comprehensively evaluating bisphosphonates' therapeutic properties to identify effective treatments for osteoporosis and other bone diseases.